Skip to main content
Equibles
INCY logo

INCY · Incyte Corp

Track INCY — free

Use INCY with AI

Ask our own analyst here, or connect this data to the AI you already use.

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$126.75 -1.25 (-0.98%) At close · Sep 4
S&P 500 member Russell 1000 member Rebalance outlook locked
Market Cap
$25.65B
Shares
199.78M

INCY metrics

71 of 114 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$126.75
Market cap
$25.65B

Price action

19 metrics
Price change (1W)
+0.2%
Price change (30D)
+8.1%
Price change (3M)
+26.4%
Price change (6M)
+31.5%
Price change (YTD)
+29.6%
Price change (1Y)
+47.2%
Trailing year
Price change (5Y)
+68.2%
52-week high
$129.93
52-week low
$81.66
Change from 52-week high
-1.5%
Change from 52-week low
+56.7%
Annualized volatility
33.1%
Beta
0.5
RSI (14D)
59.4
Price vs SMA 50
+6.3%
Price vs SMA 200
+22.4%
Avg volume (3M)
1.81M
Relative volume
0.5
Average dollar volume
$209.35M

Company

3 metrics
Sector
Healthcare
Industry
Biotechnology
Shares outstanding
199.78M

Valuation

12 metrics
P / E (TTM)
18.1
Trailing earnings · reciprocal yield 5.5%
PEG ratio
0.2
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
4.8×
reciprocal yield 20.9%
P / book
4.6
reciprocal yield 21.9%
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
16.9
reciprocal yield 5.9%
Earnings yield
5.6%

Historical valuation

8 metrics
P / E historical average (3Y)
99.7×
reciprocal yield 1.0%
P / E historical average (5Y)
66.9×
reciprocal yield 1.5%
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-07-28

Profitability

9 metrics
Gross margin
92.5%
Operating margin
30.0%
Trailing 12 months
Net margin
26.7%
Gross profit (TTM)
—
Operating profit (TTM)
$1.61B
Net income (TTM)
$1.43B
Trailing 12 months
Diluted EPS (TTM)
$7.08
FCF margin
—
Effective tax rate
19.3%

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$-0.72

Growth

11 metrics
Revenue growth YoY
+20.9%
Year over year
Net income growth YoY
+91.7%
Revenue (TTM)
$5.36B
Trailing 12 months
EPS growth YoY
+83.8%
Shares change YoY
+4.4%
Year over year · more shares
Revenue CAGR (3Y)
+14.8%
Revenue CAGR (5Y)
+14.0%
EPS CAGR (3Y)
+61.6%
EPS CAGR (5Y)
—
FCF CAGR (3Y)
+12.1%
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
25.5%
Return on assets
19.5%
Debt / equity
—
Current ratio
3.7
EBITDA (TTM)
$1.71B
Free cash flow (TTM)
—
Quick ratio
3.6
Interest coverage
689.3
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$3.46B
Total assets
$7.34B
Total debt
—

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$1.52B
Capital expenditures (TTM)
—
R&D (TTM)
$2.13B
SG&A (TTM)
$1.38B
Stock compensation (TTM)
$252.49M
R&D / revenue
39.7%
Stock compensation / revenue
4.7%

Ownership (13F)

3 metrics
13F filers
860
13F filer change QoQ
+41
Institutional ownership
101.9%

Short interest

3 metrics
Short interest
4.7%
Latest settlement · 6.7 days to cover
Days to cover
6.7d
Short-squeeze score
61 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$15.40M
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 879169 CUSIP 45337C102 13F (30d) 515 filings 493 filers Visit website